Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Clin Cancer Res. 2016 07 15; 22(14):3672-82.
View in:
PubMed
subject areas
Androgens
Androstenes
Animals
Cell Line, Tumor
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Humans
Leuprolide
Male
Mice
Mice, SCID
Phosphatidylinositol 3-Kinases
Prostate
Prostatic Neoplasms, Castration-Resistant
Receptor, ErbB-2
Receptors, Androgen
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Akash Patnaik